![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 28, 26002-26010, July 15, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








From the
Hôpital Lariboisière, U689 INSERM, IFR139, 8 rue Guy Patin, Paris 75010, France, ¶Hôpital Saint Louis, U553 INSERM, IFR105 Hôpital Saint Louis, 75010 Paris, France, ||Institut Pasteur, Paris 75724 Paris Cedex 15, France, and **Center for Molecular and Vascular Biology, University of Leuven, 3000 Leuven, Belgium
We investigated the role of two MAP kinases, ERK2 and p38, in platelet adhesion and spreading over collagen matrix in static and blood flow conditions. P38 was involved in collagen-induced platelet adhesion and spreading in static adhesion conditions, whereas ERK2 was not. In blood flow conditions, with shear rates of 300 or 1500 s1, ERK2 and p38 displayed differential involvement in platelet adhesion, depending on the presence or absence of the von Willebrand factor (vWF). Low collagen coverage densities (0.04 µg/cm2) did not support vWF binding. During perfusions over this surface, platelet adhesion was not affected by the inhibition of ERK2 phosphorylation by PD 98059. However, abolishing p38 activation by SB 203580 treatment reduced platelet adhesion by 67 ± 9% at 300 s1 and 56 ± 2% at 1500 s1. In these conditions, the p38 activity required for platelet adhesion depends on the
2
1 collagen receptor. At higher collagen coverage densities (0.8 µg/cm2) supporting vWF binding, the inhibition of ERK2 activity by PD 98059 decreased adhesion by 47 ± 6% at 300 s1 and 72 ± 3% at 1500 s1, whereas p38 inhibition had only a small effect. The ERK2 activity required for platelet adhesion was dependent on the interaction of vWF with GPIb. In conclusion, ERK2 and p38 have complementary effects in the control of platelet adhesion to collagen in a shear stress-dependent manner.
Received for publication, December 15, 2004 , and in revised form, April 25, 2005.
* This work was supported by the Association pour la Recherche sur le Cancer (ARC Contract 5820) and the Simone and Cino del Duca Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.

To whom correspondence should be addressed: Hôpital Lariboisière, U689-E6 INSERM, 8 rue Guy Patin, Paris 75010, France. Tel.: 33-1-53-20-37-80; Fax: 33-1-49-95-85-79; E-mail: marijke.bryckaert{at}larib.inserm.fr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Kauskot, F. Adam, A. Mazharian, N. Ajzenberg, E. Berrou, A. Bonnefoy, J.-P. Rosa, M. F. Hoylaerts, and M. Bryckaert Involvement of the Mitogen-activated Protein Kinase c-Jun NH2-terminal Kinase 1 in Thrombus Formation J. Biol. Chem., November 2, 2007; 282(44): 31990 - 31999. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazharian, S. Roger, E. Berrou, F. Adam, A. Kauskot, P. Nurden, M. Jandrot-Perrus, and M. Bryckaert Protease-activating Receptor-4 Induces Full Platelet Spreading on a Fibrinogen Matrix: INVOLVEMENT OF ERK2 AND p38 AND Ca2+ MOBILIZATION J. Biol. Chem., February 23, 2007; 282(8): 5478 - 5487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Begonja, J. Geiger, N. Rukoyatkina, S. Rauchfuss, S. Gambaryan, and U. Walter Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase Blood, January 15, 2007; 109(2): 616 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tang, D. Metzger, S. Leeman, and S. Amar LPS-induced TNF-{alpha} factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways PNAS, September 12, 2006; 103(37): 13777 - 13782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, G. Zhang, R. Feil, J. Han, and X. Du Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin {alpha}IIbbeta3 Blood, February 1, 2006; 107(3): 965 - 972. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |